Project Grant HT94252510237
Award Date
9/30/25
Completion Date
9/29/28
Dollars Obligated
$1M
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
College Station, TX 77843, USA
Similar Awards
The U.S. Department of Defense, Defense Health Agency has awarded a $918,000 Project Grant to the Texas A&M University System Health Science Center to conduct research on "INNATE AND ADAPTIVE IMMUNE MECHANISMS OF CD74 IN POST-TRAUMATIC EPILEPSY". This 3-year grant, running from September 15, 2024 to September 14, 2027, is funded under the Military Medical Research and Development (CFDA 12.420) program. The project aims to investigate basic and translational research on the role...
The Department of the Army Medical Command awarded $745,304 to Texas A&M University Health Science Center under the Military Medical Research and Development program (CFDA 12.420) to support the project "Epigenetic Therapy for Post-Traumatic Epilepsy" from September 30, 2022 through September 29, 2025. The project aims to develop innovative medical solutions for traumatic brain injury through basic, applied, and advanced biomedical research investigating epigenetic approaches to...
The Department of the Army Medical Command awarded a $909,291 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to the Texas A&M University System Health Science Center, Finance And Business Services Division for the project "INNATE AND ADAPTIVE IMMUNE MECHANISMS OF CD74 IN POST-TRAUMATIC EPILEPSY". The grant will fund research over a 3-year period from Sep 2024 to Sep 2027 to investigate the role of the CD74 protein in the development of...
The Defense Health Agency has awarded a $760,844.00 Project Grant to the Texas A&M University System Health Science Center to conduct research under the Military Medical Research and Development program (CFDA 12.420). The three-year grant, awarded on September 15, 2023 with a completion date of September 14, 2026, will fund research titled "Targeting the MIF/CD74 Immune Axis to Treat GWI Astrocyte, Neuronal, and Cognitive Dysfunction." This research aims to investigate medical...
This $839,745 Project Grant awarded by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) aims to improve care and outcomes for veterans with post-traumatic epilepsy. The grant was awarded to Baylor College of Medicine, a private health sciences university in Houston, Texas, to conduct research and develop new treatments in this area over the 3-year performance period from May 1, 2024 to April 30, 2027. As a leading academic medical center, Baylor...
This $785,000.00 Project Grant award, provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program, supports research at the University of California, Irvine (UCI) to investigate an endocannabinoid deficit in brain neuroinflammatory control as a potential therapeutic target for Gulf War Illness. The 3-year award, which runs from Jun 15, 2025 to Jun 14, 2028, will enable UCI's biomedical research team to conduct advanced investigations into...
The federal Project Grant award for "NEUROPHYSIOLOGY OF POST-TRAUMATIC EPILEPSY: UNRAVELING EPILEPTOGENESIS SIGNALS BIOMARKERS" was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The $860,998 award to The Regents of the University of California, San Francisco (UCSF) supports advanced biomedical research to transform healthcare for military service members, veterans, and the public. The project will investigate...
This federal Project Grant award of $707,436.00, provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), supports research to investigate "Biomarker Signatures of Post-Traumatic Epileptogenesis (PTEGenesis) and Its Treatments". The primary awardee is the Albert Einstein College of Medicine, a private non-profit educational institution, which is conducting this advanced biomedical research. The project includes a sub-award to...
The Department of the Army Medical Command, through the Military Medical Research and Development (CFDA 12.420) federal grant program, awarded Encephalogix, Inc. a $459,994 Project Grant to support epilepsy research. The award, effective from Sep 1, 2024 to Aug 31, 2025, will fund the company's "Epilepsy Research Program Idea Development Award" to explore innovative approaches to the prevention, diagnosis, treatment, and management of epilepsy, a condition relevant to military...
The Department of the Army Medical Command awarded a $755,250 Project Grant to The Ohio State University Office of Sponsored Programs through the Military Medical Research and Development federal grant program. The three-year award beginning September 30, 2022 will fund research to define the genetic basis and pathologic network of post-traumatic epilepsy using Collaborative Cross mice. As part of the Military Medical Research and Development program's goals to transform military and public...